Porton Pharma Solutions Ltd. (300363.SZ)
CNY 17.08
(0.59%)
CNY 17.08
(0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 636.87 Million | 2.56 Billion | 480.17 Million | 504.37 Million | 351.37 Million | 193.61 Million |
| Net Income | 266.85 Million | 1.93 Billion | 475.58 Million | 323.19 Million | 179.62 Million | 111.44 Million |
| Depreciation & Amortization | 379.38 Million | 259.67 Million | 192.2 Million | 131.12 Million | 116.87 Million | 124.64 Million |
| Deferred income taxes | 18.1 Million | 24.85 Million | -13.23 Million | 8.24 Million | -1.25 Million | 3.17 Million |
| Stock-based compensation | 11.21 Million | 58.33 Million | 42 Million | 26.17 Million | 10.68 Million | 2.74 Million |
| Change in working capital | -88.52 Million | 263.33 Million | -308.76 Million | -21.81 Million | -10.51 Million | -59.71 Million |
| Other non-cash items | 908.33 Million | -14.99 Million | 92.37 Million | 37.45 Million | 55.95 Million | 17.25 Million |
| Investing Cash Flow | -1.19 Billion | -1.43 Billion | -916.16 Million | -429.25 Million | 174.54 Million | -655.92 Million |
| Investments in PPE | -1.12 Billion | -1.17 Billion | -776.96 Million | -393.96 Million | -175.05 Million | -168.12 Million |
| Acquisitions | -69.65 Million | -233.32 Million | -171.09 Million | 838.88 Thousand | 67.62 Million | 69.89 Million |
| Investment purchases | -20 Million | -26.5 Million | -63.75 Million | -25 Million | -1.83 Billion | -1.68 Billion |
| Sales/Maturities of investments | 7.81 Million | 2.79 Million | 90.03 Million | 11.19 Million | 2.08 Billion | 1.11 Billion |
| Other Investing Activities | 24.94 Million | -6.1 Million | 5.61 Million | -22.32 Million | 23.48 Million | 2.88 Million |
| Financing Cash Flow | -56.53 Million | 260.83 Million | 350.21 Million | 51.94 Million | -804.81 Million | 1.52 Billion |
| Debt repayment | -620.49 Million | -1.21 Billion | -318.3 Million | -1.05 Billion | -1.57 Billion | -639.27 Million |
| Dividends payments | -601.55 Million | -105.02 Million | -65.39 Million | -55.76 Million | -25.11 Million | -74.35 Million |
| Common Stock Repurchased | -19.39 Million | -99.99 Million | - | - | -1.56 Million | -90.62 Million |
| Common Stock Issuance | - | 99.99 Million | - | - | 1.56 Million | - |
| Other Financing Activities | 19.98 Million | 1.6 Billion | 751.27 Million | 1.19 Billion | 838.98 Million | 2.23 Billion |
| Accounts receivables | 954.71 Million | -330.47 Million | -736.7 Million | -69.97 Million | -98.15 Million | -57.81 Million |
| Accounts payables | -1.17 Billion | 732.53 Million | 756.73 Million | 152.45 Million | 193.08 Million | 19.73 Million |
| Inventory | 130.04 Million | -163.58 Million | -315.55 Million | -112.54 Million | -104.19 Million | -24.8 Million |
| Other working capital | -1.15 Billion | 24.85 Million | -13.23 Million | 8.24 Million | -1.25 Million | -34.9 Million |
| Cash at beginning of period | 2.75 Billion | 1.07 Billion | 1.17 Billion | 1.07 Billion | 1.34 Billion | 277.29 Million |
| Cash at end of period | 1.96 Billion | 2.51 Billion | 1.07 Billion | 1.17 Billion | 1.07 Billion | 1.34 Billion |
| Capital Expenditure | -1.12 Billion | -1.17 Billion | -776.96 Million | -393.96 Million | -175.05 Million | -168.12 Million |
| Effect of forex changes on cash | 55.29 Million | 49.04 Million | -9.04 Million | -26.69 Million | 4.57 Million | 10.56 Million |
| Net cash flow / Change in cash | -783.85 Million | 1.43 Billion | -94.82 Million | 100.36 Million | -274.31 Million | 1.06 Billion |
| Free Cash Flow | -492.99 Million | 1.39 Billion | -296.79 Million | 110.4 Million | 176.31 Million | 25.49 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -36.39 Million | -75.16 Million | -94.87 Million | 266.85 Million | -184.99 Million | 41.48 Million |
| Depreciation & Amortization | - | 108.64 Million | 108.64 Million | 379.38 Million | 104.26 Million | -157.2 Million |
| Deferred income taxes | - | - | - | 18.1 Million | - | 1.26 Billion |
| Stock-based compensation | - | 1.55 Million | - | 11.21 Million | 11.21 Million | -24.77 Million |
| Change in working capital | - | 15.77 Million | - | -88.52 Million | 1.08 Billion | -1.08 Billion |
| Other non-cash items | 102.1 Million | 279.82 Million | 176.51 Million | 908.33 Million | -19.6 Million | 82.31 Million |
| Investing Cash Flow | -111.85 Million | -123.24 Million | -194.25 Million | -1.19 Billion | -297.13 Million | -326.57 Million |
| Investments in PPE | -111.85 Million | -123.01 Million | -180.07 Million | -1.12 Billion | -224.13 Million | -336.89 Million |
| Acquisitions | 218.68 Thousand | 336.15 Thousand | 276.17 Thousand | -69.65 Million | -70.32 Million | 395.19 Thousand |
| Investment purchases | - | - | -15 Million | -20 Million | - | -395.19 Thousand |
| Sales/Maturities of investments | - | - | - | 7.81 Million | 489.79 Thousand | 6.77 Million |
| Other Investing Activities | -1315.12 | -564.24 Thousand | 548.41 Thousand | 24.94 Million | -2.67 Million | 3.53 Million |
| Financing Cash Flow | -34.12 Million | -301.9 Million | -44.1 Million | -56.53 Million | 420.48 Million | -103.04 Million |
| Debt repayment | -16.82 Million | -17.24 Million | -18.54 Million | -620.49 Million | -409.73 Million | -138.58 Million |
| Dividends payments | -28.49 Million | -272.34 Million | -8.87 Million | -601.55 Million | -8.83 Million | -6.08 Million |
| Common Stock Repurchased | 22.18 Million | -22.18 Million | - | -19.39 Million | -19.39 Million | 724.49 Thousand |
| Common Stock Issuance | - | - | - | - | - | -724.49 Thousand |
| Other Financing Activities | -22.45 Million | -255.66 Million | -25.55 Million | 19.98 Million | 707.78 Million | 41.61 Million |
| Accounts receivables | - | 57.85 Million | - | 954.71 Million | 954.71 Million | -769.16 Million |
| Accounts payables | - | - | - | -1.17 Billion | - | - |
| Inventory | - | -42.08 Million | - | 130.04 Million | 130.04 Million | -318.35 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.46 Billion | 1.8 Billion | 1.96 Billion | 2.75 Billion | 2.12 Billion | 2.43 Billion |
| Cash at end of period | 1.38 Billion | 1.48 Billion | 1.8 Billion | 1.96 Billion | 1.96 Billion | 2.1 Billion |
| Capital Expenditure | -111.85 Million | -123.01 Million | -180.07 Million | -1.12 Billion | -224.13 Million | -336.89 Million |
| Effect of forex changes on cash | -2.01 Million | 1.79 Million | -3.19 Million | 55.29 Million | 36.03 Million | -16.04 Million |
| Net cash flow / Change in cash | -82.28 Million | -323.64 Million | -159.9 Million | -783.85 Million | -154.5 Million | -328.64 Million |
| Free Cash Flow | -46.13 Million | -27 Million | -98.43 Million | -492.99 Million | -533 Million | -219.86 Million |
2521
OEL
JDWPF
GENUSPAPER
VIO
CFPUF